Among his suggestions: better methods for tracking drug side effects, substantially less direct-to-consumer advertising, and giving the FDA the legislative authority to force drugmakers to conduct trials that fully examine the risks of their medicines.
And rather than experiment with expensive fundraising tactics, such as direct mail, he stuck to JDRF's tried-and-true methods of seeking big gifts and staging walkathons and galas.